The functional loss of the retinoblastoma tumour suppressor is a common event in basal-like and luminal B breast carcinomas
2008

Loss of RB1 in Breast Cancer Subtypes

Sample size: 88 publication 10 minutes Evidence: high

Author Information

Author(s): Herschkowitz Jason I, He Xiaping, Fan Cheng, Perou Charles M

Primary Institution: Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA

Hypothesis

The study investigates the frequency of loss of heterozygosity at the RB1 locus in different breast cancer subtypes.

Conclusion

The functional loss of RB1 is common in basal-like tumours, which may influence their aggressive behavior and treatment responses.

Supporting Evidence

  • RB1 loss of heterozygosity was found in 39% of breast cancer cases studied.
  • 72% of basal-like tumours showed RB1 loss of heterozygosity.
  • The study developed a prognostic signature based on RB1 loss.

Takeaway

In some types of breast cancer, a gene called RB1 is often missing, which can make the cancer grow faster and affect how well treatments work.

Methodology

Gene expression analysis and polymorphic markers were used to assess RB1 loss in 88 breast cancer samples.

Potential Biases

Potential biases in sample selection and analysis methods could affect the results.

Limitations

The study may not account for all genetic variations affecting RB1 function across different populations.

Participant Demographics

The study involved primary human breast carcinomas from various patients.

Statistical Information

P-Value

0.0001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/bcr2142

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication